Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Spelman

Showing results (191-200 of 266) with videos related to

Pageof 27
Sort By:
Multiple Sclerosis and Related Disorders|May 30, 2018
Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Immunity|February 27, 2026
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malariaD Herbert Opi, Rhea J Longley, Eizo Takashima, et al.
BMJ Open|September 19, 2022
PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancerVy Tran, Anne Hong, Tom Sutherland, et al.
Therapeutic Advances in Neurological Disorders|February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapiesHelmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.
BMJ Open|March 26, 2022
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocolTafireyi Marukutira, Karen P Moore, Margaret Hellard, et al.
BJU International|October 17, 2013
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer RegistrySue M Evans, Jeremy L Millar, Mark Frydenberg, et al.
BMJ Open|June 3, 2018
Treatment of scabies using a tea tree oil-based gel formulation in Australian Aboriginal children: protocol for a randomised controlled trialJackson Thomas, Rachel Davey, Gregory M Peterson, et al.
Immunology and Cell Biology|December 4, 2013
Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individualsClare L V Westhorpe, Anna Maisa, Tim Spelman, et al.
Immunology and Cell Biology|June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cellsMargaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
The Journal of Antimicrobial Chemotherapy|November 9, 2023
Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control studyChin Fen Neoh, Sharon C A Chen, David C M Kong, et al.
Pageof 27

Showing results (191-200 of 266) with videos related to

Sort By:
Pageof 27
Multiple Sclerosis and Related Disorders|May 30, 2018
Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]Yara Dadalti Fragoso, Tim Spelman, Cavit Boz, et al.
Immunity|February 27, 2026
A longitudinal study of children identifies antibody Fc-mediated functions and antigen targets of immunity to Plasmodium vivax malariaD Herbert Opi, Rhea J Longley, Eizo Takashima, et al.
BMJ Open|September 19, 2022
PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancerVy Tran, Anne Hong, Tom Sutherland, et al.
Therapeutic Advances in Neurological Disorders|February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapiesHelmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.
BMJ Open|March 26, 2022
Randomised controlled trial of active case management to link hepatitis C notifications to treatment in Tasmania, Australia: a study protocolTafireyi Marukutira, Karen P Moore, Margaret Hellard, et al.
BJU International|October 17, 2013
Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer RegistrySue M Evans, Jeremy L Millar, Mark Frydenberg, et al.
BMJ Open|June 3, 2018
Treatment of scabies using a tea tree oil-based gel formulation in Australian Aboriginal children: protocol for a randomised controlled trialJackson Thomas, Rachel Davey, Gregory M Peterson, et al.
Immunology and Cell Biology|December 4, 2013
Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individualsClare L V Westhorpe, Anna Maisa, Tim Spelman, et al.
Immunology and Cell Biology|June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cellsMargaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
The Journal of Antimicrobial Chemotherapy|November 9, 2023
Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control studyChin Fen Neoh, Sharon C A Chen, David C M Kong, et al.
Pageof 27